Post-approval studies (Phase 4)Study completedNCT01823536
What this trial is testing
Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose
Who this might be right for
Meningococcal Disease
Novartis Vaccines 465